Navigation Links
Bush Again Vetoes Embryonic Stem Cell Research Bill

President George W. Bush on Wednesday vetoed for a second time a bill seeking to encourage potentially groundbreaking embryonic stem cell research, saying it violates the sanctity of human life. Risking new criticism from the scientific community, Bush rejected moves by US lawmakers to overturn his earlier prohibition against using federal funds for any research involving human embryo destruction.

It is only the third time in six years as president that he has wielded his veto; the first time was last year when he blocked a similar bill on federal support for embryonic stem cell research. The president, a devout Christian, said that using human embryos for scientific research -- which often involves their destruction -- conflicts with his religious beliefs and he urged scientists to consider other alternatives. "If this legislation became law, it would compel American taxpayers for the first time in our history to support the deliberate destruction of human embryos," Bush said.

"I made it clear to Congress and to the American people that I will not allow our nation to cross this moral line." Embryonic stem cells are primitive cells from early stage embryos capable of developing into almost every tissue of the body. Scientists believe they could be crucial to finding a cure for a number of serious diseases, including Parkinson's and Alzheimer's, diabetes and cancer. But Bush, criticized for holding back promising research after the 2006 veto, offered new support to encouraging alternative stem cell research.

"We're already seeing remarkable advances in science and therapeutic uses of stem cells drawn from adults and children and the blood from umbilical cords with no harm to the donor," he said. "For example, several new studies released earlier this month showed the potential of reprogramming adult cells, such as skin cells, to make them function like embryonic stem cells.

"A few months earlier, scientists dis covered that cells extracted from amniotic fluid and placentas could also provide stem cells that seem to do what embryonic cells can." Bush added: "Our conscious calls us to pursue the possibilities of science in a manner that respects human dignity and upholds our moral values." Immediately after the veto, Democratic Senator Hillary Clinton hit out at Bush for holding back scientific research.

"This is just one example of how the president puts ideology before science, politics before the needs of our families," said Clinton, who is seeking the Democratic nomination for the presidential election next year. Bush also announced directives toward encouraging alternatives to stem cell research reliant on human embryos, directing the Department of Health and Human Services and the National Institutes of Health to ensure than human stem cell lines are "prodcued in ways that do not create, destroy or harm human embryos." Those that follow such orders "will be eligible for federal funding," Bush said.

Researchers have announced their recent success in reprogramming mouse skin cells to mimic the properties of embryonic stem cells, in an advance they hope can be replicated in humans. "By expanding support for nondestructive research methods, this executive order will make it more likely that these exciting advances continue to unfold," the White House said after Bush signed the executive order.

As before, Bush's rejection of the legislation does not prevent private money to be used for embryonic stem cell work. Private foundations and some states have offered funds for research with embryonic stem cells in the wake of Bush's previous veto.


'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. Spinal Cord Patients Walk Again
4. New Weapon Against Germs
5. Estrogen Found To Protect the Colon Against Cancer
6. Diet Found To Offer Protection Against Leukemia
7. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
8. WHO Issues Caution Against Bird Flu Epidemic
9. New Supplement Found To Be Effective Against Sunburn
10. Intense Fight Against Polio In India Gets Results
11. Prime Minister Manmohan Against Incentive-Based Population Control
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology: